SCHEMBL7039474

SCHEMBL7039474

Cc1ccnc(NCCCC(=O)NCC(=O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGAV P06756 7/20 0.57
ITGB6 P18564 7/20 0.57
ITGB3 P05106 6/20 0.57
ITGB5 P18084 6/20 0.57
ITGA2B P08514 3/20 0.55
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ITGB1 P05556 1/20 0.51
ITGA5 P08648 1/20 0.51
ALDH1A1 P00352 1/20 0.50
KDM4D Q6B0I6 1/20 0.45
NOS2 P35228 1/20 0.45
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28804474 0.90 ITGAV (0.56) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL30446650 0.87 ITGAV (0.54) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL7170034 0.86 ITGB3 (0.54) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL25840750 0.86 ITGAV (0.53) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL24341476 0.85 ITGAV (0.52) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL26031769 0.83 ITGAV (0.50) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL26033637 0.83 ITGAV (0.52) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL5856027 0.82 ITGB3 (0.58) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL7172179 0.81 ITGB3 (0.57) ITGAVITGB6ITGB3ITGB5ITGA2B
SCHEMBL6589410 0.81 ITGB3 (0.53) ITGAVITGB6ITGB3ITGB5ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171304-A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof MERCK PATENT GMBH (DE) 2003-09-11 US disclosed
EP-1290010-A1 PYRIDINE-2-YL-AMINOALKYL CARBONYL GLYCYL-$G(B)-ALANINE AND DERIVATIVES THEREOF MERCK PATENT GmbH (DE) 2003-03-12 EP disclosed
WO-2001096365-A1 PYRIDINE-2-YL-AMINOALKYL CARBONYL GLYCYL-$G(B)-ALANINE AND DERIVATIVES THEREOF MERCK PATENT GMBH (DE) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171304-A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof GLRB, GLRA3, HAO2 ITGAV 2128/4885ITGB6 681/4885ITGB3 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.